Rebekah Ziegman

Rebekah Ziegman

Auto-generated profile, based on publicly available information

Rebekah Ziegman

Institute for Molecular Bioscience, University of Queensland, St. Lucia, QLD 4072, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2021 in Proteomics
Verified
Journal Article
Closed access
PDF file
PPParthiban Periasamy
Parthiban Periasamy
SRSureka Rajandran
Sureka Rajandran
RZRebekah Ziegman
Rebekah Ziegman
MCMika Casey
Mika Casey
KNKyohei Nakamura
Kyohei Nakamura
HGHarsha Gowda
Harsha Gowda

24 January 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RFRocio Finol-Urdaneta
Rocio Finol-Urdaneta
RZRebekah Ziegman
Rebekah Ziegman
ZDZoltan Dekan
Zoltan Dekan
JMJeffrey McArthur
Jeffrey McArthur
SHStewart Heitmann
Stewart Heitmann
PAPaul Alewood
Paul Alewood
The King Baboon spider, Pelinobius muticus, is a burrowing African tarantula. Its impressive size and appealing coloration are tempered by reports describing severe localized pain, swelling, itchiness, and muscle cramping after accidental envenomation. Hyperalgesia is the most prominent symptom after bites from P. muticus, but the molecular basis by which the venom induces pain is unknown. Proteotranscriptomic analysis of P. muticus venom uncovered a cysteine-rich peptide, δ/κ-theraphotoxin-Pm1a (δ/κ-TRTX-Pm1a), that elicited nocifensive behavior when injected into mice. In small dorsal root ganglion neurons, synthetic δ/κ-TRTX-Pm1a (sPm1a) induced hyperexcitability by enhancing tetrodotoxin-resistant sodium currents, impairing repolarization and lowering the threshold of action potential firing, consistent with the severe pain associated with envenomation. The molecular mechanism of nociceptor sensitization by sPm1a involves multimodal actions over several ion channel targets, including NaV1.8, KV2.1, and tetrodotoxin-sensitive NaV channels. The promiscuous targeting of peptides like δ/κ-TRTX-Pm1a may be an evolutionary adaptation in pain-inducing defensive venoms. Significance Pain development and discomfort are universal features of spider envenomation, yet severe pain arising from bites by Old World spiders is poorly understood. Molecular analyses of the venom of the King Baboon spider revealed abundant expression of the inhibitory cystine knot peptide Pm1a. Synthetic Pm1a induces pain in mice while simultaneously enhancing proexcitatory sodium currents and decreasing inhibitory potassium currents. These concomitant effects promote hyperexcitability in pain-sensing neurons that can be reversed by pharmacological inhibition of voltage-gated sodium channels. The coordinated modulation of excitatory and inhibitory ion channels involved in pain propagation may represent an economical and effective defense strategy in pain-inducing defensive venoms.

30 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KDKeshava K. Datta
Keshava K. Datta
PPParthiban Periasamy
Parthiban Periasamy
SMSonali V. Mohan
Sonali V. Mohan
RZRebekah Ziegman
Rebekah Ziegman
HGHarsha Gowda
Harsha Gowda
Hypoxia is a common feature in various solid tumours, including melanoma. Cancer cells in hypoxic environments are resistant to both chemotherapy and radiation. Hypoxia is also associated with immune suppression. Identification of proteins and pathways that regulate cancer cell survival in hypoxic environments can reveal potential vulnerabilities that can be exploited to improve the efficacy of anticancer therapies. We carried out temporal proteomic and phosphoproteomic profiling in melanoma cell lines to identify hypoxia-induced protein expression and phosphorylation changes. By employing a TMT-based quantitative proteomics strategy, we report the identification and quantitation of >7000 proteins and >10,000 phosphosites in melanoma cell lines grown in hypoxia. Proteomics data show metabolic reprogramming as one of the prominent adaptive responses in hypoxia. We identify several novel hypoxia-mediated phosphorylation changes that have not been reported before. They reveal kinase signalling pathways that are potentially involved in modulating cellular response to hypoxia. In addition to known protein expression changes, we identify several novel proteomic alterations associated with adaptive response to hypoxia. We show that cancer cells require the ubiquitin–proteasome system to survive in both normoxia and hypoxia. Inhibition of proteasome activity affects cell survival and may provide a novel therapeutic avenue to target cancer cells in hypoxia. Our study can serve as a valuable resource to pursue novel candidates to target hypoxia in cancers and improve the efficacy of anticancer therapies.

1 March 2021 in STAR Protocols
Verified
Journal Article
Open access
SMSonali V. Mohan
Sonali V. Mohan
KDKeshava K. Datta
Keshava K. Datta
RZRebekah Ziegman
Rebekah Ziegman
CSCorey Smith
Corey Smith
HGHarsha Gowda
Harsha Gowda
Major histocompatibility complexes (MHC) play a critical role in immunity by presenting peptides on the cell surface for T cell recognition. Identification of these peptides can be valuable to develop vaccines or immunotherapeutic strategies for infectious diseases and cancers. Mass spectrometry is the only tool available for unbiased identification of the immunopeptidome. Here, we describe a protocol for purification and identification of MHC class I peptides, including in-house purification of anti-MHC-antibody from hybridoma cells and the LC-MS/MS analysis of MHC-I bound peptides.